BioSpace News Archive

Sun Nuclear, a wholly-owned subsidiary of Mirion Technologies, Inc., announced that it has designated Scripps Health as a Patient Safety Center of Excellence.

Twist Bioscience Corporation announced the shipments of the first products from its second manufacturing site, the Factory of the Future, in Wilsonville, Oregon.

BioCentriq, Inc announced today that they’ve completed a study designed to test transfection of T-cells with GFP mRNA for evaluation of cell viability, transfection efficiency, and post transfection growth using Kytopen’s Flowfect® technology.

Devonian Health Group Inc. is pleased to announce that Mr. Pierre Montanaro, President and Chief Executive Officer of the Corporation, is scheduled to present at the BIO CEO & Investor Conference taking place at the New York Marriott Marquis on February 6-9, 2023.

Syros Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to tamibarotene for the treatment of higher-risk myelodysplastic syndrome (HR-MDS).

Akeso, Inc. announced the Hart-Scott-Rodino (HSR) Act filing has cleared for the previously announced collaboration and license agreement between Akeso and Summit Therapeutics (the “Summit”) for the breakthrough bispecific antibody, Ivonescimab (PD-1/VEGF). Akeso had received the first tranche of the upfront payment of US$300 million.

Emergent Health Corp. (OTC PINK:EMGE), a curator, developer and marketer of products in the Regenerative Health Space announced today that it has executed a Letter of Intent to acquire Nanosthetic Corp.

OpGen, Inc. and OpGen subsidiary, Ares Genetics (Ares) announced today the granting of a key patent by the China National Intellectual Property Administration (CNIPA).

Agenus today announced that Dr. Garo Armen, Chairman and CEO, and Dr. Steven O’Day, Chief Medical Officer, will participate in the following upcoming investor conferences.

Cybin Inc. today announced that it will host a virtual R&D Day on Tuesday, February 28, 2023, from 10:00 a.m. ET to 11:30 a.m. ET.